Evidence map›Paper›PMID 34769005›Full record

ReviewInternational journal of molecular sciences2021

Current Concepts of Psoriasis Immunopathogenesis.

Marijana Vičić, Marija Kaštelan, Ines Brajac, Vlatka Sotošek, Larisa Prpić Massari

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07169019 (Gut Microbiome Changes and Clinical Impact Induced by Treatment of Newly Diagnosed Psoriasis Patients With Probiotics and Methotrexate), which is not on this map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07169019 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Gut Microbiome Changes and Clinical Impact Induced by Treatment of Newly Diagnosed Psoriasis Patients With Probiotics and Methotrexate: a Pilot Study

TypeinterventionalSponsorAlexandria UniversityRan2025 to 2026Enrolled24ConditionsPsoriasis (PsO)ArmsProbiotics and methotrexate, Methotrexate
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. CEACAM5 drives psoriatic inflammation by regulating CD8Biochemistry and biophysics reports · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Tm4sf19 inhibition alleviates imiquimod-induced psoriatic dermatitis by regulating inflammatory signaling pathways and keratinocyte proliferation in mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  8. Genetic Association Study ofLife (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Evaluation of Atherosclerosis Risk in Patients with Psoriasis.Clinical, cosmetic and investigational dermatology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marijana VičićDepartment of Dermatovenereology, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.
Marija KaštelanDepartment of Dermatovenereology, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.
Ines BrajacDepartment of Dermatovenereology, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.
Vlatka SotošekDepartment of Anesthesiology, Reanimation and Intensive Care, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Tome Strižića 3, 51000 Rijeka, Croatia.
Larisa Prpić MassariDepartment of Dermatovenereology, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0003-3572-6197
University of Rijeka · HR

Funding

University of Rijeka biomed-uniri-18-43
6 · The paper itself

Abstract

Psoriasis is a recurrent, chronic, immune-mediated, systemic inflammatory disease of the skin, joints, and other organic systems. After atopic dermatitis, chronic stationary psoriasis is the most common inflammatory skin disease, affecting an average of 2-4% of the world's population. The disease carries a significant burden due to its numerous comorbidities and the major impact on patients' social and emotional aspects of life. According to current knowledge, psoriasis is a multifactorial disease that occurs in genetically predisposed individuals under various environmental factors, which trigger an immune response disorder with a series of complex inflammatory cascades. The disease is initiated and maintained by mutual interaction of the innate and adaptive immune cells, primarily dendritic cells, T lymphocytes, and keratinocytes, whose leading role alternates at different stages of the disease, consisting mainly in the IL-23/Th17 pathway. Inflammatory events result in consequent epidermal and dermal changes and evolution of the characteristic psoriatic phenotype, respectively. This paper aims to present a comprehensive overview of current knowledge on psoriasis genetic and environmental etiological factors, immunopathogenesis, and the leading cellular and cytokine participants in the inflammatory pathways of this disease.

Indexed as

AnimalsCytokinesHumansInflammationKeratinocytesPhenotypePsoriasisSignal TransductionCytokinesdendritic cellsetiologyIL-23/Th17 pathwayimmunopathogenesiskeratinocytesmacrophagesNK cellsNKT cellspsoriasisT lymphocytes

Identifiers

PMID34769005
PMCPMC8584028
OpenAlexW3209863967

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.